Mrs. Fatemeh Akbarzadeh | Physics in Medicine | New Horizons Science Invention Award
Medical Physicist at Guilan University of Medical Sciences, Iran
Fatemeh Akbarzadeh is a medical physicist from Rasht, Guilan, Iran, specializing in cancer treatment, targeted therapy, and drug delivery. With a strong academic background, she has made significant contributions to research and innovation in her field. Fatemeh has a robust publication record, with several papers in reputable journals and a patent for synthesizing bismuth oxide nanoparticles for targeted drug delivery. Her professional experience includes roles as a medical physicist in various hospitals, where she has applied her knowledge to enhance cancer treatment protocols. Fatemeh’s research interests encompass various cutting-edge areas, including photodynamic therapy, radiation therapy, and nanotechnology. She is dedicated to advancing cancer diagnostics and treatment, making her a prominent figure in her field. With her commitment to research, Fatemeh is well-equipped to contribute significantly to the scientific community and healthcare innovation.
Professional Profile
Education✍️
Fatemeh Akbarzadeh’s educational journey reflects her dedication to the field of medical physics and radiotherapy technology. She earned her Master of Science in Medical Physics from Kermanshah University of Medical Sciences in 2018, achieving an impressive GPA of 3.953 out of 4.00 (18.76 out of 20). This academic excellence showcases her strong grasp of complex concepts and methodologies in medical physics. Prior to her Master’s degree, she completed her Bachelor of Science in Radiotherapy Technology at Tehran University of Medical Sciences in 2014, graduating with a GPA of 3.670 out of 4.00 (17.20 out of 20). This foundational education equipped her with essential skills and knowledge, laying the groundwork for her research and professional pursuits. Throughout her studies, Fatemeh honed her abilities in both theoretical and practical aspects of medical physics, which would later influence her research interests and professional roles. Her educational achievements demonstrate her commitment to excellence and a passion for advancing healthcare through scientific research.
Professional Experience♻️
Fatemeh Akbarzadeh’s professional experience spans several roles in medical physics, highlighting her expertise in the field. Currently, she serves as a medical physicist in the Department of Radiotherapy at Razi Hospital in Rasht, Guilan, where she has been employed since 2024. In this role, Fatemeh applies her knowledge to enhance cancer treatment protocols and ensure patient safety through effective radiation management. Previously, she worked as a medical physicist at Velayat Hospital in Qazvin from 2021 to 2024 and at Razi Hospital from 2019 to 2021. These positions have provided her with hands-on experience in clinical settings, allowing her to integrate her research findings into practical applications. Additionally, Fatemeh held the position of laboratory expert in the Toxicology and Pharmacology Department at Kermanshah University of Medical Sciences from 2017 to 2018, where she conducted various experiments under the supervision of Dr. Leila Hosseinzadeh. Her diverse experiences in both laboratory and clinical environments have equipped her with a comprehensive understanding of medical physics and its applications in cancer treatment.
Research Interest🧬
Fatemeh Akbarzadeh’s research interests center on advancing cancer treatment and diagnosis through innovative technologies and methodologies. She focuses on several key areas, including cancer treatment, targeted therapy, drug delivery systems, photodynamic therapy, and radiation therapy. Her work often explores the integration of nanotechnology in cancer diagnosis and treatment, aiming to improve therapeutic efficacy and minimize side effects. In addition to her interest in treatment modalities, Fatemeh is keen on studying radiobiology and dosimetry, which are critical for optimizing radiation therapy techniques. She has contributed significantly to the field through her publications, addressing topics such as the cytotoxicity of bismuth oxide nanoparticles and their application in photodynamic therapy. By investigating the interplay between novel drug delivery systems and traditional cancer treatments, Fatemeh seeks to enhance patient outcomes and contribute to the development of more effective therapeutic strategies. Her dedication to research and innovation positions her as a promising figure in the realm of cancer treatment and medical physics.
Award and Honors🏆
Publications top noted✍️
- Authors: H Norouzi, K Khoshgard, F Akbarzadeh
Year: 2018
Citation: Norouzi H, Khoshgard K, Akbarzadeh F. In vitro outlook of gold nanoparticles in photo-thermal therapy: a literature review. Lasers in Medical Science. 33, 917-926. - Authors: F Akbarzadeh, K Khoshgard, L Hosseinzadeh, E Arkan, D Rezazadeh
Year: 2018
Citation: Akbarzadeh F, Khoshgard K, Hosseinzadeh L, Arkan E, Rezazadeh D. Investigating the cytotoxicity of folate-conjugated bismuth oxide nanoparticles on KB and A549 cell lines. Advanced Pharmaceutical Bulletin. 8(4), 627. - Authors: F Akbarzadeh, K Khoshgard, E Arkan, L Hosseinzadeh, …
Year: 2018
Citation: Akbarzadeh F, Khoshgard K, Arkan E, Hosseinzadeh L, et al. Evaluating the photodynamic therapy efficacy using 5-aminolevulinic acid and folic acid-conjugated bismuth oxide nanoparticles on human nasopharyngeal carcinoma cell line. Artificial Cells, Nanomedicine, and Biotechnology. 46(sup3), S514-S523. - Authors: N Amin, A Afkhami, L Hosseinzadeh, F Akbarzadeh, T Madrakian, …
Year: 2020
Citation: Amin N, Afkhami A, Hosseinzadeh L, Akbarzadeh F, Madrakian T, et al. Ratiometric bioassay and visualization of dopamine β-hydroxylase in brain cells utilizing a nanohybrid fluorescence probe. Analytica Chimica Acta. 1105, 187-196. - Authors: F Akbarzadeh, K Khoshgard
Year: 2024
Citation: Akbarzadeh F, Khoshgard K. Enhancement of the effect of novel targeted 5-aminolevulinic acid conjugated bismuth oxide nanoparticles-based photodynamic therapy by simultaneous radiotherapy on KB cells. Photodiagnosis and Photodynamic Therapy. 46, 104025. - Authors: F Akbarzadeh, K Khoshgard, L Hosseinzadeh, E Arkan
Year: 2018
Citation: Akbarzadeh F, Khoshgard K, Hosseinzadeh L, Arkan E. Cytotoxicity of 5-ALA-conjugated bismuth oxide nanoparticles on KB cell line. Iranian Journal of Medical Physics. 15(Special Issue-12th Iranian Congress). - Authors: F Akbarzadeh, K Khoshgard, L Hosseinzadeh, E Arkan, D Rezazadeh
Year: 2018
Citation: Akbarzadeh F, Khoshgard K, Hosseinzadeh L, Arkan E, Rezazadeh D. Investigating the cytotoxicity of folate and 5-aminolevulinic acid-conjugated bismuth oxide nanoparticles on KB and A549 cell lines.